comprehensive -WSS

comprehensive

author：entertainment 2025-09-06 04:37:04 - browse：54772

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Hospitals are dialing back on venture capital investing

hotspot

WSS

Maui wildfire now ranks as the fifth

What to know about the judge who will handle the Trump case

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Surge in Apellis stock fueled by confidence in safety of its eye drug

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Illumina slashes 2023 revenue projections yet again

focus

comprehensive

entertainment

How one medical school became remarkably diverse

After Optum profits sink, UnitedHealth makes changes

Cancer drug shortages should be causing more outrage

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

In Memoriam: Notable people who died in 2023

How to bring more disabled researchers into academia

In age of alternative facts, a scholarly course on calling out crap

RSV shot was 90% effective at preventing hospitalizations in kids

In Memoriam: Notable people who died in 2023

Amylyx ALS drug fails large clinical trial

Wikipedia

Change Healthcare payments predicted restored March 15

After Optum profits sink, UnitedHealth makes changes

Just how do doctors, lawmakers, and the public define abortion?

Maui wildfire now ranks as the fifth

Biden administration begins canceling student loan debt for 804,000 borrowers

Senators push IRS to launch nonprofit hospital probe

hotspot

knowledge

hotspot

entertainment